The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 28, 2021
Filed:
Oct. 24, 2019
Applicant:
Sanofi, Paris, FR;
Inventors:
Marielle Chiron-Blondel, Paris, FR;
Diether Lambrechts, Leuven, BE;
Emmanuelle Magherini, Ris Orangis, FR;
Vincent Thuillier, Bures sur Yvette, FR;
Assignee:
SANOFI, Paris, FR;
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/71 (2006.01); G01N 33/574 (2006.01); A61K 9/00 (2006.01); A61K 38/00 (2006.01); A61K 31/282 (2006.01); A61K 31/4745 (2006.01); A61K 31/513 (2006.01); A61K 31/519 (2006.01);
U.S. Cl.
CPC ...
C07K 14/71 (2013.01); A61K 9/0019 (2013.01); A61K 31/282 (2013.01); A61K 31/4745 (2013.01); A61K 31/513 (2013.01); A61K 31/519 (2013.01); G01N 33/57419 (2013.01); A61K 38/00 (2013.01); C07K 2319/30 (2013.01); G01N 2333/5421 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention concerns the use of interleukin-8 (IL-8) as a biomarker for predicting the outcome of the treatment with aflibercept, or ziv-aflibercept of a patient suspected to suffer from a cancer.